R&D Targets definition

R&D Targets means the results and milestones set forth in a Project Plan that determine whether Amyris has successfully completed its obligations with respect to the research and development of [*] Products.

Examples of R&D Targets in a sentence

  • At the expiration of the R&D Term, (i) all R&D Programs will become “Discontinued Programs” (ii) all R&D Targets and R&D [***] Targets that are not Locked Targets will become Discontinued Targets and (iii) all Collaboration mRNA Constructs that are not in a Product Candidate Pool will become Discontinued mRNA Constructs.

  • The most important documents used are strategic documents stating R&D Targets for 2016, 2017 and 2018, various press releases and a video communication where the newly appointed CEO of the vendor discusses his thoughts on the organization and its future.

  • The JSC will maintain a current list of all R&D Program Pathogens, R&D Targets and R&D [***] Targets included in each R&D Program.

  • Project Operations Biodiesel R&D Targets: Feedstock (Phase 1) - A hybrid mustard breeding contract with the University of Idaho has been modified to expand the focus on pesticide varieties and their impacts on farm systems.

  • Bidders should clearly specify whether discounts quoted are inclusive of GST/duties/statutory charges or such charges as extra.

  • R&D Targets Technical reports – Expertises – Studies – Patents – Education&Training – Publications – Projects and Proposals - E/Self – learning, TEL – Standards - Testing - OtherUSERS * R&D staff from Centres/Universities/Industry/Government/ Regions/...

Related to R&D Targets

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • KPI Target means the acceptable performance level for a KPI as set out in each KPI;

  • Soft Target means a target that will suffer minimum damage and cause minimum damage to the subject vehicle in the event of a collision.

  • Targets means pre-agreed values to be achieved at the end of the period in relation to the result indicators included under a specific objective;

  • Development Candidate means a Collaboration Compound designated by Biogen Idec as a Development Candidate in accordance with Section 2.6.

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Research Plan shall have the meaning set forth in Section 2.1.

  • Research Program Term has the meaning set forth in Section 2.2.

  • Research Program has the meaning set forth in Section 2.1.

  • Development Milestone Event has the meaning set forth in Section 7.1.

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • Milestones means control points in the project that help to chart progress. Milestones may correspond to the completion of a key deliverable, allowing the next phase of the work to begin. They may also be needed at intermediary points so that, if problems have arisen, corrective measures can be taken. A milestone may be a critical decision point in the project where, for example, the consortium must decide which of several technologies to adopt for further development.

  • Development Milestone Payment shall have the meaning set forth in Section 9.2(a).

  • Research-based means a program or practice that has been

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Development Plan has the meaning set forth in Section 3.2.

  • EBITDA Target means the Company's projected earnings before interest, taxes, one-time transition expenses, non-cash compensation expense charges, depreciation and amortization, as contained in the Company's budget for the Applicable Period and which is approved by the Board (without reference to any adjustments or revision, upwards or downwards, to such projected earnings which are subsequently approved by the Board as part of any subsequent revision to such budget), and (ii) the term "Financial Results" shall mean the Company's EBITDA calculated by reference to the Company's financial statements for the Applicable Period as filed with the Securities and Exchange Commission (the "SEC").

  • Performance Targets means the specific objective goal or goals (which may be cumulative and/or alternative) that are timely set in writing by the Committee for each Executive for the Performance Period in respect of any one or more of the Business Criteria.

  • GSK will have the meaning set forth in the Preamble.

  • Development Program means the implementation of the development plan.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Development Team means the entities and professionals assembled to develop and manage the Project, typically including the Applicant, Owner, Developer(s), Co-Developer(s) and general partner or any other related entities in which the Developer or Co-Developer has an identity of interest or a Controlling Interest.

  • Licensed Compound means [***].

  • Research Budget has the meaning set forth in Section 2.2.

  • Antibody means a molecule or a gene encoding such a molecule comprising or containing one or more immunoglobulin variable domains or parts of such domains or any existing or future fragments, variants, modifications or derivatives thereof.